Sponsor:
Allogene Therapeutics
Code:
NCT04696731
Conditions
Advanced/Metastatic Clear Cell Renal Cell Carcinoma
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
ALLO-316
ALLO-647
Fludarabine
Cyclophosphamide
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations